AwardedPOLGoods
Sukcesywne dostawy produktu leczniczego Talkwetamab dla Narodowego Instytutu Onkologii im. Marii Skłodowskiej-Curie - Państwowego Instytutu Badawczego Oddziału w Gliwicach
- Published
- Published 9 April 2026
Overview
The National Institute of Oncology in Gliwice procured successive deliveries of the pharmaceutical product Talkwetamab through a direct award procedure. Janssen-Cilag Polska Sp. z o.o. was awarded the contract valued at 332,499.92 PLN on 8 April 2026, with deliveries scheduled successively through 1 July 2026 or until exhaustion of the buyer's financial limit, whichever occurs first.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 9 April 2026
Pharmaceutical products
Award outcome
- Awarded value
- PLN 332,500
- Award date
- 8 April 2026
- Contract period
- 10 April 2026 → 1 July 2026
- Janssen-Cilag Polska Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
16 April 2026
Contract Notice
9 April 2026
Contracting authority
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Oddział w Gliwicach
Procuring entityGliwice, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.